Pulmonary Tuberculosis Chemotherapy Regimen — free guideline decision tool
This tool gives the standardized pulmonary tuberculosis chemotherapy regimen by new, retreatment, or drug-resistant status, with principles and monitoring.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Pulmonary Tuberculosis Chemotherapy Regimen do?
Use to select the regimen — 2HRZE/4HR for new susceptible TB, susceptibility-guided retreatment, and an individualized MDR regimen with referral.
How is the result calculated?
New susceptible → 2HRZE/4HR (6 months) with DOT. Retreatment → susceptibility-guided (classically streptomycin-containing). RR/MDR → individualized regimen (bedaquiline, linezolid) by susceptibility, specialist-managed.
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Pulmonary Tuberculosis Chemotherapy Regimen now
This tool gives the standardized pulmonary tuberculosis chemotherapy regimen by new, retreatment, or drug-resistant status, with principles and monitoring.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.